
After another financing round has been completed, US-based Vtv Therapeutics has secured an additional USD 10m funding, this time from investment firm Cinpax, the biotech firm reports in a press release.
The investment comes hot on the heels of G42 Healthcare’s USD 25m injection into the biotech company, bringing the total of raised funds over a short time to USD 35m.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app